Gut microbiota and obesity: Concepts relevant to clinical care

European Journal of Internal Medicine

Volumn 48, Issue , 2018, Pages 18-24

  Dao, Maria Carlota ^a,b   Clément, Karine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Gut microbiota; Metabolic disease; Obesity

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

AKKERMANSIA MUCINIPHILA; BARIATRIC SURGERY; BODY WEIGHT LOSS; CALORIC RESTRICTION; COMORBIDITY; DIET; FECAL MICROBIOTA TRANSPLANTATION; GRAM NEGATIVE BACTERIUM; HEALTH; HOST; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; METABOLIC DISORDER; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; OBESITY MANAGEMENT; REVIEW; SPECIES; GASTROINTESTINAL TRACT; MICROBIOLOGY;

GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; METABOLIC DISEASES; OBESITY; WEIGHT LOSS;

EID: 85032216371     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2017.10.005     Document Type: Review

References (108)

1. Zhao, L., The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11 (2013), 639–647, 10.1038/nrmicro3089.
2. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249, 10.1038/nature11552.
3. Khan, M.T., Nieuwdorp, M., Bäckhed, F., Microbial modulation of insulin sensitivity. Cell Metab 20 (2014), 753–760, 10.1016/j.cmet.2014.07.006.
4. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G. et al., Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546, 10.1038/nature12506.
5. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B. et al., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103, 10.1038/nature12198.
6. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F. et al., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60, 10.1038/nature11450.
7. Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C. et al., Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE, 8, 2013, e71108, 10.1371/journal.pone.0071108.
8. Kirpich, I.A., Marsano, L.S., McClain, C.J., Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem 48 (2015), 923–930, 10.1016/j.clinbiochem.2015.06.023.
9. Karlsson, F.H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D. et al., Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 3, 2012, 1245, 10.1038/ncomms2266.
10. GD, Wu, Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A. et al., Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108, 10.1126/science.1208344.
11. Kong, L.C., Holmes, B.A., Cotillard, A., Habi-Rachedi, F., Brazeilles, R., Gougis, S. et al., Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE, 9, 2014, e109434, 10.1371/journal.pone.0109434.
12. Griffin, N.W., Ahern, P.P., Cheng, J., Heath, A.C., Ilkayeva, O., Newgard, C.B. et al., Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe 21 (2017), 84–96, 10.1016/j.chom.2016.12.006.
13. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L. et al., Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214, 10.1126/science.1241214.
14. Cho, I., Yamanishi, S., Cox, L., Methé B.A., Zavadil, J., Li, K. et al., Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488 (2012), 621–626, 10.1038/nature11400.
15. de la Cuesta-Zuluaga, J., Mueller, N.T., Corrales-Agudelo, V., Velásquez-Mejía, E.P., Carmona, J.A., Abad, J.M. et al., Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40 (2017), 54–62, 10.2337/dc16-1324.
16. Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T.W., Lee, M.-S. et al., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2013), 727–735, 10.1136/gutjnl-2012-303839.
17. Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S. et al., Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266, 10.1038/nature15766.
18. Klaassen, C.D., Cui, J.Y., Review: mechanisms of how the intestinal microbiota alters the effects of drugs and bile acids. Drug Metab Dispos 43 (2015), 1505–1521, 10.1124/dmd.115.065698.
19. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772, 10.2337/db06-1491.
20. Erridge, C., Attina, T., Spickett, C.M., Webb, D.J., A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86 (2007), 1286–1292.
21. Postler, T.S., Ghosh, S., Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab 26 (2017), 110–130, 10.1016/j.cmet.2017.05.008.
22. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64, 10.1038/nature18846.
23. Morrison, D.J., Preston, T., Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (2016), 189–200, 10.1080/19490976.2015.1134082.
24. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1131, 10.1038/nature05414.
25. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C. et al., Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18 (2010), 190–195, 10.1038/oby.2009.167.
26. Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11 (2015), 577–591, 10.1038/nrendo.2015.128.
27. Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L. et al., The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 5, 2014, 3611, 10.1038/ncomms4611.
28. Monteiro-Sepulveda, M., Touch, S., Mendes-Sá C., André S., Poitou, C., Allatif, O. et al., Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling. Cell Metab 22 (2015), 113–124, 10.1016/j.cmet.2015.05.020.
29. Touch, S., Clément, K., André S., T cell populations and functions are altered in human obesity and type 2 diabetes. Curr Diab Rep, 17, 2017, 81, 10.1007/s11892-017-0900-5.
30. Eckle, S.B.G., Corbett, A.J., Keller, A.N., Chen, Z., Godfrey, D.I., Liu, L. et al., Recognition of vitamin B precursors and byproducts by mucosal associated invariant T cells. J Biol Chem 290 (2015), 30204–30211, 10.1074/jbc.R115.685990.
31. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T. et al., Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19 (2013), 576–585, 10.1038/nm.3145.
32. Tang, W.H.W., Hazen, S.L., The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 124 (2014), 4204–4211, 10.1172/JCI72331.
33. Tang, W.H.W., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X. et al., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368 (2013), 1575–1584, 10.1056/NEJMoa1109400.
34. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A.H. et al., Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381, 10.1038/nature18646.
35. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F. et al., A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9 (2009), 311–326, 10.1016/j.cmet.2009.02.002.
36. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M. et al., Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227, 10.1038/nature11053.
37. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S. et al., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107 (2010), 14691–14696, 10.1073/pnas.1005963107.
38. Schnorr, S.L., Candela, M., Rampelli, S., Centanni, M., Consolandi, C., Basaglia, G. et al., Gut microbiome of the Hadza hunter-gatherers. Nat Commun, 5, 2014, 3654, 10.1038/ncomms4654.
39. Clemente, J.C., Pehrsson, E.C., Blaser, M.J., Sandhu, K., Gao, Z., Wang, B. et al., The microbiome of uncontacted Amerindians. Sci Adv, 1, 2015, 10.1126/sciadv.1500183.
40. Liu, H., Hu, C., Zhang, X., Jia, W., Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig, 2017, 10.1111/jdi.12687.
41. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E. et al., Dietary intervention impact on gut microbial gene richness. Nature 500 (2013), 585–588, 10.1038/nature12480.
42. Beaumont, M., Goodrich, J.K., Jackson, M.A., Yet, I., Davenport, E.R., Vieira-Silva, S. et al., Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol, 17, 2016, 189, 10.1186/s13059-016-1052-7.
43. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E. et al., A core gut microbiome in obese and lean twins. Nature 457 (2008), 480–484, 10.1038/nature07540.
44. Menni, C., Jackson, M.A., Pallister, T., Steves, C.J., Spector, T.D., Valdes, A.M., Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain. Int J Obes, 2005, 2017, 10.1038/ijo.2017.66 (41:1099–105).
45. Sze, M.A., Schloss, P.D., Looking for a signal in the noise: revisiting obesity and the microbiome. MBio, 7, 2016, 10.1128/mBio.01018-16.
46. Derrien, M., Belzer, C., de Vos, W.M., Akkermansia muciniphila and its role in regulating host functions. Microb Pathog 106 (2017), 171–181, 10.1016/j.micpath.2016.02.005.
47. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O. et al., Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65 (2015), 426–436, 10.1136/gutjnl-2014-308778.
48. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B. et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci 110 (2013), 9066–9071, 10.1073/pnas.1219451110.
49. Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L. et al., A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23 (2017), 107–113, 10.1038/nm.4236.
50. Ouwerkerk, J.P., Aalvink, S., Belzer, C., De Vos, W.M., Preparation and preservation of viable Akkermansia muciniphila cells for therapeutic interventions. Benefic Microbes 8 (2017), 163–169, 10.3920/BM2016.0096.
51. Anhê F.F., Roy, D., Pilon, G., Dudonné S., Matamoros, S., Varin, T.V. et al., A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64 (2014), 872–883, 10.1136/gutjnl-2014-307142.
52. Roopchand, D.E., Carmody, R.N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P.J. et al., Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64 (2015), 2847–2858, 10.2337/db14-1916.
53. Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P.D., Bäckhed, F., Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22 (2015), 658–668, 10.1016/j.cmet.2015.07.026.
54. Jakobsdottir, G., Xu, J., Molin, G., Ahrné S., Nyman, M., High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS ONE, 8, 2013, e80476, 10.1371/journal.pone.0080476.
55. Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54 (2004), 1469–1476, 10.1099/ijs.0.02873-0.
56. Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H. et al., Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of epithelial cell layer. Appl Environ Microbiol, 2015, 10.1128/AEM.04050-14.
57. Derrien, M., Van Baarlen, P., Hooiveld, G., Norin, E., Müller, M., de Vos, W.M., Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol, 2, 2011, 166, 10.3389/fmicb.2011.00166.
58. Ottman, N., Reunanen, J., Meijerink, M., Pietilä T.E., Kainulainen, V., Klievink, J. et al., Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PloS One, 12, 2017, e0173004, 10.1371/journal.pone.0173004.
59. Greer, R.L., Dong, X., Moraes, A.C.F., Zielke, R.A., Fernandes, G.R., Peremyslova, E. et al., Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat Commun, 7, 2016, 13329, 10.1038/ncomms13329.
60. Dao, M.C., Everard, A., Clément, K., Cani, P.D., Losing weight for a better health: role for the gut microbiota. Clin Nutr Exp 6 (2016), 39–58, 10.1016/j.yclnex.2015.12.001.
61. Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215, 10.1038/nature16504.
62. Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T. et al., Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 22 (2015), 971–982, 10.1016/j.cmet.2015.10.001.
63. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A. et al., Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094, 10.1016/j.cell.2015.11.001.
64. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E. et al., Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab 22 (2015), 320–331, 10.1016/j.cmet.2015.07.001.
65. David, L.A., Materna, A.C., Friedman, J., Campos-Baptista, M.I., Blackburn, M.C., Perrotta, A. et al., Host lifestyle affects human microbiota on daily timescales. Genome Biol, 15, 2014, R89, 10.1186/gb-2014-15-7-r89.
66. Nguyen, N.T., Varela, J.E., Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 14 (2017), 160–169, 10.1038/nrgastro.2016.170.
67. Aron-Wisnewsky, J., Doré J., Clement, K., The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol 9 (2012), 590–598, 10.1038/nrgastro.2012.161.
68. Madsbad, S., Dirksen, C., Holst, J.J., Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol 2 (2014), 152–164, 10.1016/s2213-8587(13)70218-3.
69. Liou, A.P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P.J., Kaplan, L.M., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med, 5, 2013, 10.1126/scitranslmed.3005687 (178ra41-178ra41).
70. Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y. et al., Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci 106 (2009), 2365–2370, 10.1073/pnas.0812600106.
71. Graessler, J., Qin, Y., Zhong, H., Zhang, J., Licinio, J., Wong, M.-L. et al., Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 13 (2012), 514–522, 10.1038/tpj.2012.43.
72. Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T. et al., Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22 (2015), 228–238, 10.1016/j.cmet.2015.07.009.
73. Palleja, A., Kashani, A., Allin, K.H., Nielsen, T., Zhang, C., Li, Y. et al., Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med, 8, 2016, 67, 10.1186/s13073-016-0312-1.
74. Kong, L.-C., Tap, J., Aron-Wisnewsky, J., Pelloux, V., Basdevant, A., Bouillot, J.-L. et al., Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 98 (2013), 16–24, 10.3945/ajcn.113.058743.
75. Patrone, V., Vajana, E., Minuti, A., Callegari, M.L., Federico, A., Loguercio, C. et al., Postoperative changes in fecal bacterial communities and fermentation products in obese patients undergoing bilio-intestinal bypass. Front Microbiol, 7, 2016, 200, 10.3389/fmicb.2016.00200.
76. Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L. et al., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59 (2010), 3049–3057, 10.2337/db10-0253.
77. Damms-Machado, A., Mitra, S., Schollenberger, A.E., Kramer, K.M., Meile, T., Königsrainer, A. et al., Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int 2015 (2015), 1–12, 10.1155/2015/806248.
78. Aron-Wisnewsky, J., Clement, K., The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep, 16, 2014, 10.1007/s11883-014-0454-9.
79. Verger, E.O., Aron-Wisnewsky, J., Dao, M.C., Kayser, B.D., Oppert, J.-M., Bouillot, J.-L. et al., Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up. Obes Surg 26 (2015), 785–796, 10.1007/s11695-015-1803-7.
80. Kohli, R., Bradley, D., Setchell, K.D., Eagon, J.C., Abumrad, N., Klein, S., Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 98 (2013), E708–712, 10.1210/jc.2012-3736.
81. Ilhan, Z.E., DiBaise, J.K., Isern, N.G., Hoyt, D.W., Marcus, A.K., Kang, D.-W. et al., Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding. ISME J 11 (2017), 2047–2058, 10.1038/ismej.2017.71.
82. Murphy, R., Tsai, P., Jüllig, M., Liu, A., Plank, L., Booth, M., Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg 27 (2017), 917–925, 10.1007/s11695-016-2399-2.
83. Albaugh, V.L., Flynn, C.R., Cai, S., Xiao, Y., Tamboli, R.A., Abumrad, N.N., Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids. J Clin Endocrinol Metab 100 (2015), E1225–1233, 10.1210/jc.2015-2467.
84. Patti, M.-E., Houten, S.M., Bianco, A.C., Bernier, R., Larsen, P.R., Holst, J.J. et al., Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obes Silver Spring Md 17 (2009), 1671–1677, 10.1038/oby.2009.102.
85. Ahmad, N.N., Pfalzer, A., Kaplan, L.M., Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes, 2005, 2013, 10.1038/ijo.2013.38 (37:1553–9).
86. Ryan, K.K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R. et al., FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509 (2014), 183–188, 10.1038/nature13135.
87. Kaska, L., Sledzinski, T., Chomiczewska, A., Dettlaff-Pokora, A., Swierczynski, J., Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol 22 (2016), 8698–8719, 10.3748/wjg.v22.i39.8698.
88. Cani, P.D., Van Hul, M., Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 32 (2015), 21–27, 10.1016/j.copbio.2014.10.006.
89. Park, S., Bae, J.-H., Probiotics for weight loss: a systematic review and meta-analysis. Nutr Res 35 (2015), 566–575, 10.1016/j.nutres.2015.05.008.
90. Delzenne, N.M., Neyrinck, A.M., Bäckhed, F., Cani, P.D., Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7 (2011), 639–646, 10.1038/nrendo.2011.126.
91. Sanchez, M., Darimont, C., Panahi, S., Drapeau, V., Marette, A., Taylor, V.H. et al., Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Forum Nutr, 9, 2017, 10.3390/nu9030284.
92. Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E. et al., Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 111 (2014), 1507–1519, 10.1017/S0007114513003875.
93. Madjd, A., Taylor, M.A., Mousavi, N., Delavari, A., Malekzadeh, R., Macdonald, I.A. et al., Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. Am J Clin Nutr 103 (2016), 323–329, 10.3945/ajcn.115.120170.
94. Woodard, G.A., Encarnacion, B., Downey, J.R., Peraza, J., Chong, K., Hernandez-Boussard, T. et al., Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg Off J Soc Surg Aliment Tract 13 (2009), 1198–1204, 10.1007/s11605-009-0891-x.
95. Chen, J.J., Wang, R., Li, X., Wang, R., Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med 236 (2011), 823–831, 10.1258/ebm.2011.010399.
96. Sherf-Dagan, S., Zelber-Sagi, S., Zilberman-Schapira, G., Webb, M., Buch, A., Keidar, A. et al., Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. Int J Obes (Lond), 2017, 2005, 10.1038/ijo.2017.210.
97. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A. et al., The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci 101 (2004), 15718–15723, 10.1073/pnas.0407076101.
98. Bäckhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci 104 (2007), 979–984, 10.1073/pnas.0605374104.
99. Khoruts, A., Sadowsky, M.J., Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 13 (2016), 508–516, 10.1038/nrgastro.2016.98.
100. Singh, R., Nieuwdorp, M., ten Berge, I.J.M., Bemelman, F.J., Geerlings, S.E., The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20 (2014), 1119–1125, 10.1111/1469-0691.12799.
101. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., Bartelsman, J.F.W.M. et al., Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.e7, 10.1053/j.gastro.2012.06.031.
102. Li, S.S., Zhu, A., Benes, V., Costea, P.I., Hercog, R., Hildebrand, F. et al., Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589, 10.1126/science.aad8852.
103. Marotz, C.A., Zarrinpar, A., Treating obesity and metabolic syndrome with fecal microbiota transplantation. Yale J Biol Med 89 (2016), 383–388.
104. van Nood, E., Speelman, P., Nieuwdorp, M., Keller, J., Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 30 (2014), 34–39, 10.1097/MOG.0000000000000024.
105. Bojanova, D.P., Bordenstein, S.R., Fecal transplants: what is being transferred?. PLoS Biol, 14, 2016, e1002503, 10.1371/journal.pbio.1002503.
106. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K. et al., Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564, 10.1126/science.aad3503.
107. Pfeiffer, J.K., Virgin, H.W., Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine. Science, 351, 2016, 10.1126/science.aad5872.
108. Magalhaes, I., Pingris, K., Poitou, C., Bessoles, S., Venteclef, N., Kiaf, B. et al., Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 125 (2015), 1752–1762, 10.1172/JCI78941.